baber/WOPTO huggingface dataset:
Patent DK-354685-D0 (DK)
Inventor: BROMLEY CHARLES WILLIAM ALFRED
IPC: C08F2/08
Filed: 1985-08-05
Abstract: A coating composition which is especially suitable for producing decorative coatings upon wood substrates comprises, as at least 51 % by weight of the film-forming material present, a sterically stabilised dispersion in a volatile organic liquid of insoluble vinyl or acrylic polymer particles, the polymer having an extensibility of 50-2000% and being crosslinked to such an extent that it has a gel content of at least 35% by weight.
Patent DK-389784-D0 (DK)
Inventor: VIEHE HEINZ
IPC: A61K31/675
Filed: 1984-08-14
Abstract: PCT No. PCT/BE83/00022 Sec. 371 Date Aug. 23, 1984 Sec. 102(e) Date Aug. 23, 1984 PCT Filed Dec. 20, 1983 PCT Pub. No. WO84/02523 PCT Pub. Date Jul. 5, 1984.The acylated enamide compounds are acylated enamides corresponding to the general formula  <IMAGE>  in which Z represents an electron donor group, n is 1, 2 or 3, and R1 represents hydrogen, a halogen or any organic group, or salts, complexes, alkylated derivatives or acylated derivatives of these compounds. Typical acylated enamide compounds according to the invention correspond to the formula  <IMAGE>  These acylated enamide compounds and the pharmaceutical compositions containing the compounds are useful in the prevention and treatment of cancers.
Patent DK-394685-D0 (DK)
Inventor: DELL HANS-DIETER
IPC: A61K9/52
Filed: 1985-08-29
Abstract: 1. Sustained-release formulation of acemetacin based on encapsulated multiple unit doses in the form of pellets containing a physiologpally innocuous substance of relatively high specific gravity, characterized in that it consists of an initial dose which contains 10 to 60% by weight of the total amount of acemetacin and if appropriate additives, and a pellet formulation which contains the remaining amount of the active compound, a disintegrating agent, a binder and a substance having a relatively high specific gravity and is coated with a lacquer which is resistant to gastric juice, the individual pellets having a diameter of 0.2 to 1.8 mm.
Patent DK-422588-D0 (DK)
Inventor: BORSETH DONALD
IPC: C08F20/04
Filed: 1988-07-28
Abstract: A surfactant-modified polymer characterized in that it comprises a polycarboxylate backbone and at least 0.5 percent by weight nonionic surfactant chemically associated therewith, the surfactant-modified polymer being formed by the polymerization of a reactant compound selected from carboxylic acids, polycarboxylic acids and mixtures thereof in an aqueous media in the presence of a nonionic surfactant is disclosed.
Patent DK-664787-D0 (DK)
Inventor: WAGNER JACK FREDRICK
IPC: A61K38/25
Filed: 1987-12-17
Abstract: The concentration of endogenous growth hormone in the bloodstream of an economic mammal is increased by the simultaneous administration of an estrogen and a growth hormone releasing factor.
Patent HU-903970-D0 (HU)
Title: Process for producing new plasmins and their utilization for obtaining a new plasminogene activator
Inventor: BRIGELIUS-FLOHE REGINA E
IPC: C12N9/64
Filed: 1990-06-25
Abstract: Plasmids with synthetic DNA sequences, which are suitable for expressing a precursor protein of rscu-PA (that is to say the unglycosylated protein portion of the single-chain prourokinase) in Enterobacteriaceae, especially E. coli, in an amount which is considerably above the yields which can be achieved using plasmids of the state of the art, are described. The plasmids according to the invention are characterised in that their operon has a controllable, optionally synthetic promoter, a Shine-Dalgarno sequence, a start codon, a synthetic structural gene and, downstream from the structural gene, at least one terminator. The preparation of the plasmids and of the synthetic DNA sequences starting from commercially available plasmids etc. is described. The precursor protein of rscu-PA which is expressed at a high rate using them can be refolded in a manner known per se to give the rscu-PA which can be employed therapeutically as plasminogen activator and which can then, if required, also be employed for cleavage, which is carried out in a manner known per se, to obtain the two-chain unglycosylated urokinase protein (rtcu-PA) on the industrial scale. <IMAGE>
Patent HU-904388-D0 (HU)
Title: Method for recovering recombinant proteins
Inventor: MEHROTRA VIKRAM P
IPC: C07K1/30
Filed: 1990-05-10
Abstract: A method for recovering a recombinant protein from a protein solution containing high molecular weight containing proteins by directly adding amine or quaternary ammonium compounds to the solution in amounts sufficient to selectively precipitate the high molecular weight protein contaminants. The high molecular weight precipitates are removed and the solution is further processed to remove low molecular weight contaminating proteins and other non-protein contaminants. The recombinant protein is subsequently recovered and further processed to produce a protein composition suitable for its intended use.
Patent NO-880459-D0 (NO)
Inventor: CLARKSON DOUGLAS
IPC: C02F1/50
Filed: 1988-02-02
Abstract: A method of treating an aqueous or non-aqueous dfsystem is disclosed which comprises adding to the system a thiolan of the formula <CHEM> wherein each of X and Y, which may be the same or different, represents fluorine, chlorine or bromine, in combination with a sulphone of the formula:    R1 - SO2 CH = @ - R2 in which R1 represents an optionally halogenated alkyl radical or an optionally subsituted aryl radical, R2 represents a cyano of amidocarbonyl radical and X represents a halogen atom.
Patent NO-880720-D0 (NO)
Inventor: CANONGE MICHEL
IPC: C07C67/03
Filed: 1988-02-18
Abstract: The invention relates to a process for the continuous preparation of acetates by a transesterification reaction in the homogeneous liquid phase in the presence of a catalyst selected from metallic alcoholates. The process comprises more particularly the introduction of the catalyst into a reactor (R) and the introduction of the reagents, formed by an acetate (I) and an alcohol (II), into a distillation column (D1) surmounting the reactor (R) and operating at a pressure (P1) identical with that in (R). The acetate (III) formed is withdrawn from (R) mixed with the catalyst, which is separated and recycled in (R). An azeotropic mixture (M1), comprising the acetate (I) and the alcohol (IV) formed, emergences at the head of (D1) and feeds a distillation column (D2) at a pressure (P2) lower than (P1), so as to produce at the head of the column an azeotropic mixture (M2) depleted in alcohol (IV), the mixture being recycled in (D1). The process permits the use of relatively humid reagents and alcohols of low reactivity, more particularly secondary alcohols.
Patent NO-880845-D0 (NO)
Inventor: NASSIM MICHAEL ARNOLD
IPC: A61K9/12
Filed: 1988-02-26
Abstract: There are described a new compound, methods for its preparation and compositions containing it. Calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8 -dicarboxy late is a novel compound and is useful in the treatment of reversible obstructive airways disease and/or the prevention or treatment of rhinitis.
Patent NO-880948-D0 (NO)
Inventor: DAVIS ROBERT E
IPC: B65D5/44
Filed: 1988-03-03
Abstract: A multicell carrier comprising a generally rectangular body defined by end (30,32) and side walls (26,28) and a bottom wall (34, 36), an upstanding divider (24) positioned within said body and extending between and secured to said end walls, said divider including projecting partition members secured to said side walls and an upper handle portion (48) formed integrally with said divider, said carrier being improved by said body being formed from a body blank (50) and said divider and said handle (24) being formed from a separately formed combined divider and handle blank (52). A method of forming a multicell carrier (20) of the type including a body (22), internal dividers and a handle (24), said method comprising the steps of forming a body blank (50) and separately forming a combined divider and handle blank (52), and joining said combined divider and handle blank (52) to said body blank (50) to form a knocked-down multicell carrier.
Patent NO-882744-D0 (NO)
Inventor: SUNDHOLM GOERAN
IPC: B08B9/032
Filed: 1988-06-21
Abstract: PCT No. PCT/FI87/00138 Sec. 371 Date Feb. 28, 1989 Sec. 102(e) Date Feb. 28, 1989 PCT Filed Oct. 20, 1987 PCT Pub. No. WO88/03065 PCT Pub. Date May 5, 1988.The invention relates to an apparatus for flushing a hydraulic small-diameter pipe system or the like. Two pressure accumulators (33a and 33b) are arranged at one end of the pipe system (20), connectable alternately to the pipe system and to a tank (39), for receiving a volume of liquid corresponding to volumes of gas and liquid, respectively, which are alternately introduced into the opposite end of the pipe systems for filling the pipe system with alternating columns (42, 43) of flushing liquid and compressed gas, and on achieving a predetermined pressure in the pipe system, the pipe system is opened into a receiving tank, whereby the compressed gas is suddenly expanded and drives a forceful flushing pulse through the pipe system.
Patent NO-891002-D0 (NO)
Inventor: LANGER RUTH
IPC: E04G1/14
Filed: 1989-03-08
Abstract: The corner connection for scaffolding provides, between the vertical pole (15) made of aluminium and the horizontal bar (17) made of aluminium, two external gusset plates (20) which are welded, with simple seam geometry and while avoiding excess local heating, into the corner as bracing. <IMAGE>
Patent NO-912097-D0 (NO)
Inventor: STRID KENT
IPC: B01D29/62
Filed: 1991-05-31
Abstract: PCT No. PCT/SE90/00639 Sec. 371 Date May 30, 1991 Sec. 102(e) Date May 30, 1991 PCT Filed Oct. 4, 1990 PCT Pub. No. WO91/04778 PCT Pub. Date Apr. 18, 1991.In a method for filtering a suspension through a stationary filter having a vertical filter element arranged in a pressure vessel and for re-conditioning the filter after filtering, the filtrate is discharged from the bottom of the filter element during the main part of the filtering. After filtering, unfiltered suspension is discharged in a known manner from the pressure vessel later to be returned to the suspension inlet. Thereafter, back-wash is performed with another medium other than filtrate, an outlet for material deposited on the filter element being opened for removal of said material together with the back-washing medium. Preferably, before back-wash, drying of the material deposited on the filter element takes place by means of a gas medium circulating within the filtering plant.
Patent NO-921186-D0 (NO)
Inventor: NORISTI LUCIANO
IPC: C08F110/00
Filed: 1992-03-26
Abstract: Catalyst components for the polymerization of olefins, obtained by reacting a tetravalent titanium halide or halogen alcoholate and an electron-donor compound with a solid comprising a porous metallic oxide containing hydroxyl groups on the surface, on which is supported a magnesium dihalide or a magnesium compound which does not contain Mg-C bonds and can be transformed into a dihalide, characterized in that the quantity of Mg supported on the oxide prior to the reaction with titanium compound, and present in the catalyst component after the reaction with the Ti compound, is from 5% to 12% weight with respect to the weight of the catalyst component.
Patent NO-923463-D0 (NO)
Inventor: CARLSTROEM BOERGE
IPC: F16L13/00
Filed: 1992-09-04
Abstract: The sleeve (21) consists of an essentially cylindrical outer layer (22) of glass-fibre-reinforced plastic and an inner layer (23) consisting of polyurethane. Approximately in the centre between the two sleeve ends (21a, 21b), this inner layer has a rib (26) which is used as a stop for the ends of the two pipes (24, 25) which are to be joined to one another. Between this rib (26) and the one sleeve end (21a), the sleeve has an approximately conical internal shape, which has a diameter which increases towards the outside, this conical surface (27) also being provided with two sealing beads (28, 29). A cylindrical section (33), a sawtooth-shaped rib (35) and an annular groove (36) are located between the other sleeve end (21b) and the rib (26). Such a sleeve can be fitted relatively easily onto the end of a pipe (24) and can also be joined thereto, by means of an adhesive, such that it cannot be detached. A pipe (25) having an essentially identical diameter can be inserted into the other sleeve end, which pipe is seated in a sealed manner in the sleeve even if the axes (30, 37) of the sleeve (21) and pipe (25) do not coincide but form a small angle with one another. <IMAGE>
Patent NO-924032-D0 (NO)
Inventor: PLACE VIRGIL A
IPC: A61K9/02
Filed: 1992-10-19
Abstract: Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. For impotence, the agents include vasodilators, for priapism, the agents include vasoconstrictors and for Peyronie's disease, the agents include anti-inflammatory agents. The agents are preferably administered to the urethra by means of a penile insert (1) having a rapidly releasing coating (4) of the agent on its exterior surface or by means of an inserter (27) carrying a load of agent (31) which can be displaced into the urethra.
Patent NO-930788-D0 (NO)
Inventor: COULAIT DAVID JOSEPH KENNETH
IPC: A61F13/56
Filed: 1993-03-04
Abstract: A disposable absorbent article, such as a diaper, having an improved tape fastener system is disclosed. The improved tape fastener system comprises a mechanical fastening means, initial adhesive securement means, and a reserve/protected adhesive securement means. The mechanical fastening means provide for effective side closure of the absorbent article, whereas the initial adhesive securement means provides a convenient initial disposal mechanism by which the absorbent article may be folded or rolled up into a configuration for disposal, secured in the disposal configuration, and thrown away. If the initial disposal adhesive becomes contaminated or insufficient for securing the absorbent article in its disposal configuration, the reserve/protected adhesive is available for use, with only minimal additional effort.
Patent NO-934070-D0 (NO)
Inventor: HABBERSTAD BENT JOHN
IPC: E04B1/68
Filed: 1993-11-10
Abstract: PCT No. PCT/NO94/00176 Sec. 371 Date Apr. 30, 1996 Sec. 102(e) Date Apr. 30, 1996 PCT Filed Nov. 7, 1994 PCT Pub. No. WO95/13438 PCT Pub. Date May 18, 1995A device for sealing concrete joints is provided. The sealing device includes an elongate section (8) having a larger width than thickness (t). The section (8) has longitudinal edge portions (12, 13) and is intended for casting into two concrete structures (1, 2) for sealing a concrete joint area between the two structures (1,2). A swellable material (7, 14) is provided at least at the longitudinal edge portions (12, 13) thereof. The section (8) is made of a substantially rigid material and is provided with an internal cavity extending over a major part of its width.
Patent NO-940421-D0 (NO)
Inventor: ROBERTSSON JAMES RICHARD
IPC: C08F220/06
Filed: 1994-02-08
Abstract: Antimicrobial quaternary ammonium group-containing organosilicon polymers, aqueous disinfectant solutions containing such polymers, and lenses produced from such polymers are provided herein. The polymers are produced by homopolymerizing or copolymerizing, with a suitable comonomer, a quaternary ammonium group-containing organosilicon monomer of formula I as defined herein. A preferred monomer of formula I is the monomer of formula II: <CHEM> 3-methacryloxypropyltetramethyldisiloxanylpropyldimethyloctadecylammonium chloride (MADAC).
Patent NO-942400-D0 (NO)
IPC: C07C255/39
Filed: 1994-06-23
Abstract: Process for obtg. an isomer of a nitrile of formula RCH(CN)R1 (I), or a racemic- modification contg. isomer and enantiomer, comprising treatment of the epimer of the enantiomer, or a racemic- modification comprising epimer and enantiomer, in soln. or in slurry, in a polar organic solvent, with a source of cyanide ions in absence of a base; the prod. being less soluble in the solvent or diluent than the substrate, is new. In (I) R, R1 = any organic radical linked directly or through a heteroatom to the C atom bearing the CN gp.; provided that at least one of R, R1 contains at least one resolved chiral centre stable under the conditions of the process.
Patent NO-944223-D0 (NO)
Inventor: KOPP-HOLTWIESCHE BETTINA
IPC: C09K23/14
Filed: 1994-11-04
Abstract: PCT No. PCT/EP93/01323 Sec. 371 Date Dec. 1, 1994 Sec. 102(e) Date Dec. 1, 1994 PCT Filed May 26, 1993 PCT Pub. No. WO93/24612 PCT Pub. Date Dec. 9, 1993A nutrient concentrate for stimulation of growth for the accelerated cultivation and growth of hydrocarbon-consuming microorganisms as well as a process for their use in bioremediation is disclosed. The concentrate is an admixture of water-soluble and/or oil-soluble compounds of phosphorus (P) and nitrogen (N) and other components. The concentrate is in the form of a liquid water-based preparation and contains an ester of phosphoric acid as both an emulsifier and a P source. Further, from 10 to 40% by weight urea is contained in the concentrate as a N source. The invention also relates to the treatment of polluted soils, waters, and articles using a diluted aqueous solution of the concentrated admixture.
Patent NO-951775-D0 (NO)
Inventor: JOHANSSON ROLF ARNE
IPC: A61K31/195
Filed: 1995-05-05
Abstract: The invention relates to 3,3-diphenylpropylamines of formula (I), wherein R1 signifies hydrogen or methyl, R2 and R3 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphamoyl or halogen, and X represents a tertiary amino group of formula (II), wherein R4 and R5 signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and wherein R4 and R5 may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers. The invention also relates to methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs
Patent NO-955272-D0 (NO)
Inventor: AU HANS-RUDOLF AUS DER
IPC: B29K267/00
Filed: 1995-12-22
Abstract: For the manufacture of substantially hollow-cylindrical castings (5), especially leading-in insulators for conductors under high voltage, a more or less liquid casting material (50) is introduced into a substantially hollow-cylindrical casting mould (2) that is driven in rotation. Before the introduction of the casting material, the casting mould is heated to a temperature above the gelling temperature of the casting material. The casting mould (2) filled with casting material (50) is driven in rotation until a casting (5) that is substantially set solid has been formed. The casting so formed is then removed from the casting mould. Before the introduction of the casting material into the casting mould, however, a substantially hollow-cylindrical mesh fabric (1) is introduced into the heated casting mould (2) concentrically to the axis of rotation (22) thereof, and only then is the casting material (50) introduced into the casting mould (2).
Patent NO-962136-D0 (NO)
Inventor: MILLER ROBERT G
IPC: C08G18/42
Filed: 1996-05-24
Abstract: A condom of thermoplastic elastomer is drawn from a polyesterurethane.
Patent NO-962287-D0 (NO)
Inventor: CREMER KARSTEN
IPC: A61K9/20
Filed: 1996-06-03
Abstract: A device for the controlled release of active substances in liquid media from an active substance-containing matrix exhibiting active substance releasing-surfaces has, the active substance releasing surfaces of the matrix covered, at least partially, by an erodible mass of solids; the thickness of the erodible mass across its extent on the active substance releasing-areas is determined by gradients.
Patent NO-975989-D0 (NO)
Inventor: RINALDI MURIELLE
IPC: C07D209/08
Filed: 1997-12-19
Abstract: The use of human CB2 receptor-specific agonists of formula (I) or (I') for preparing immunomodulating drugs is disclosed. In formulae (I) and (I'), R1 is a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11, -CHR9CH2NR'6R'11, -(CH2)nZ and -COR8; R'1 is a -CH2CHR10NR6R11 or -(CH2)2NR'6R'11 group; R2 and R'2 are hydrogen, halogen or C1-4 alkyl; R3 is hydrogen, C1-4 alkyl or a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11 and -COR8; R'3 is a =CR6R8 group; R4 has one of the meanings given for R5 or is a -COR8 group; R5 is hydrogen, C1-4 alkyl, C1-4 alkoxy, a halogen atom, a CF3 group, an OCF3 group or C1-4 alkylthio; R'5 has one of the meanings given for R5 and is in the 5 or 6 position of the indene ring; R6 is hydrogen or C1-4 alkyl; R'6 is C1-4 alkyl; R7 has one of the meanings given for R5 or R7 and R9 together form a -Y-CH2- group attached to the indole ring in the 7 position by a group Y; R8 is phenyl substituted one to four times by a substituent selected from halogen, C1-4 alkyl or C1-4 alkoxy; a polycyclic ring selected from naphth-1-yl, naphth-2-yl, 1,2,3,4-tetrahydronaphth-1-yl, 1,2,3,4-tetrahydronaphth-5-yl, anthryl, benzofuryl, benzothien-2-yl, benzothien-3-yl, 2-, 3-, 4- or 8-quinolyl, said polycyclic rings optionally being substituted once or twice by a substituent selected from C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halogen, cyano, hydroxyl, trifluoromethyl and imidazol-1-yl; R10 and R11 together are a group selected from -CH2-O-CH2-CR12R13- and -(CH2)p-CR12R13-, wherein the carbon atom substituted by R12 and R13 is attached to the nitrogen atom; R'11 is C1-4 alkyl; or R'11 and R'6, taken together with the nitrogen atom to which they are attached, form a group selected from morpholin-4-yl, thiomorpholin-4-yl, piperidin-1-yl and pyrrolidin-1-yl; each of R12 and R13 is independently hydrogen or C1-4 alkyl; n is 2, 3, 4 or 5; p is 2 or 3; Z is a methyl group or a halogen atom; and Y is a methylene group or an oxygen atom.
Patent NO-983627-D0 (NO)
Inventor: SALFELD JOCHEN G
IPC: A61P37/02
Filed: 1998-08-07
Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed. These antibodies have high affinity for hTNFα (e.g., Kd=10−8 M or less), a slow off rate for hTNFα dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize hTNFα activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFα and for inhibiting hTNFα activity, e.g., in a human subject suffering from a disorder in which hTNFα activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.